Rheumatologists' awareness of and screening practices for hepatitis B virus infection prior to initiating immunomodulatory therapy.
about
Autoimmune-like drug-induced liver injury: a review and update for the clinician.Review article: prescribing medications in patients with cirrhosis - a practical guide.Risk of hepatitis B virus reactivation in rheumatoid arthritis patients undergoing biologic treatment: Extending perspective from old to newer drugs.Poor recognition of risk factors for hepatitis B by physicians prescribing immunosuppressive therapy: a call for universal rather than risk-based screening.Past hepatitis B virus infection in rheumatoid arthritis patients receiving biological and/or nonbiological disease-modifying antirheumatic drugsSafety of biologic and nonbiologic disease-modifying antirheumatic drug therapy in veterans with rheumatoid arthritis and hepatitis B virus infection: a retrospective cohort studyReactivation of hepatitis B during immunosuppressive therapy: potentially fatal yet preventable.Hepatitis B reactivation during cancer chemotherapy: an international survey of the membership of the American Association for the Study of Liver DiseasesHepatitis B Virus Reactivation in the Setting of Cancer Chemotherapy and Other Immunosuppressive Drug Therapy.Hepatitis B Serology in Patients with Rheumatic DiseasesCurrent antiviral practice and course of Hepatitis B virus infection in inflammatory arthritis: a multicentric observational study (A + HBV study).Viral hepatitis: review of arthritic complications and therapy for arthritis in the presence of active HBV/HCV.Reactivation of occult hepatitis B virus infection in patients with rheumatic diseases: pathogenesis, risk assessment and prevention.Gastroenterologists Have Suboptimal Hepatitis B Virus Screening Rates in Patients Receiving Immunosuppressive Therapy.The practice pattern of hepatitis b testing in rheumatoid arthritis patients: A cross-national comparison between US and Taiwan.Perception of hepatitis B virus infection reactivation-related issues among specialists managing hematologic malignancies: result of an Italian survey.Anti-TNF therapy in patients with HBV infection--analysis of 87 patients with inflammatory arthritis.Practice Patterns in Hepatitis B Virus Screening Before Cancer Chemotherapy in a Major US Hospital Network.Prospective study of HBV reactivation risk in rheumatoid arthritis patients who received conventional disease-modifying antirheumatic drugs.
P2860
Q30276377-9301C52F-C9B6-4F98-9D79-A030441CFB43Q34342554-A5A386B0-E96E-49BD-8855-AAE2019E2B97Q35237316-0B96D2CD-2FF0-4655-AB19-36B018EB37BFQ35429416-DBC74382-515F-4718-B0D8-A9F2A9B10425Q35610251-51FF5A81-600E-4C66-9C8B-DE29C8F2CA27Q35809610-64DC1A0D-D36C-41F6-9F6B-583C92AE71B9Q36311839-446D78B0-A6C9-433B-A964-078DE8C65CA8Q36803202-39D43E38-7C2B-43E1-B0B3-BA6DA6DB5B8FQ36958944-1CAC99C8-3F17-4840-BBD3-8626DACF5983Q37291847-E9E36DC4-C78D-4DED-94CD-E4AD5E7C03DCQ37305100-322382E7-FCF9-418D-9ACF-2BED0284068FQ38084182-2CE4CA94-0B6B-4C11-A5A4-ACA548A631FFQ38634826-A0116B15-A836-45DF-86CF-76CE1C6C0AEAQ39906266-75C1EED6-A8CD-47BC-BBA0-38A198311EFBQ40284619-E40BACDD-4406-47D7-8196-54929D88251AQ42240548-D6B1822D-63AA-456A-99EE-B7AB4C9E9E8BQ42265897-6D082BB6-6703-461F-97D3-5865B2471767Q45324215-66D2DE34-B6D7-4DC2-BEB0-03C6F647A973Q46162379-8390562A-D063-4182-9C76-BF3A8E7EE5BE
P2860
Rheumatologists' awareness of and screening practices for hepatitis B virus infection prior to initiating immunomodulatory therapy.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Rheumatologists' awareness of ...... ting immunomodulatory therapy.
@en
Rheumatologists' awareness of ...... ting immunomodulatory therapy.
@nl
type
label
Rheumatologists' awareness of ...... ting immunomodulatory therapy.
@en
Rheumatologists' awareness of ...... ting immunomodulatory therapy.
@nl
prefLabel
Rheumatologists' awareness of ...... ting immunomodulatory therapy.
@en
Rheumatologists' awareness of ...... ting immunomodulatory therapy.
@nl
P2093
P2860
P356
P1476
Rheumatologists' awareness of ...... ting immunomodulatory therapy.
@en
P2093
James H Lewis
John Charalambopoulos
Omar S Khokhar
Victoria K Shanmugam
P2860
P304
P356
10.1002/ACR.20209
P577
2010-05-01T00:00:00Z